Compare Oruka Therapeutics Inc. Common Stock (ORKA) vs Uranium Energy Corp (UEC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Oruka Therapeutics Inc. Common Stock vs Uranium Energy Corp — how do they compare? Oruka Therapeutics Inc. Common Stock trades at $76.8 (market cap $5.08B), while Uranium Energy Corp trades at $7.48 (market cap $3.82B). The key difference: Oruka Therapeutics Inc. Common Stock is the larger of the two by market cap, and Oruka Therapeutics Inc. Common Stock is trading nearer its 52-week high, Uranium Energy Corp nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Oruka Therapeutics Inc. Common Stock for 0 Days and Uranium Energy Corp for 38 Days on average.
| ORKA | UEC | |
|---|---|---|
Market Cap | $5.08B | $3.82B |
Volume | 685,276 | 13,882,337 |
Sector | Health | Energy |
52-Week High | $113.08 | $20.14 |
52-Week Low | $26.19 | $7.70 |
Typical Hold Time | 0 Days | 38 Days |
Enterprise Value | $4.21B | $3.32B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Uranium Energy (UEC) trades at $8.25, down 6.57% today, amid bearish technical signals despite strong analyst support. The company shows mixed fundamentals with revenue of $66.84M in 2025 but significant losses (-$87.66M net income), while expanding production capacity with two operational mines. Recent news highlights operational improvements and growing U.S. government demand for domestic uranium.
Outlook remains speculative with high execution risk; while analyst consensus is bullish (87.5% buy ratings, $16.06 target), persistent negative margins and cash burn require careful monitoring. Investment opportunity hinges on successful production scaling and uranium price sustainability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →About Uranium Energy Corp
Uranium Energy Corp is a leading American uranium mining and exploration company, currently holding the largest resource base and licensed production capacity in the United States. Utilizing low-cost, environmentally friendly In-Situ Recovery (ISR) mining, UEC is a central player in the domestic nuclear fuel supply chain, transitioning from a resource holder to an active producer and refiner to meet the accelerating demand for carbon-free energy.
Read more on UEC →
